Submitted by Anonymous (not verified) on 16 October 2025 - 13:05
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 15, Status: Authorised